NOVO NORDISK: ANNOUNCES LAUNCH OF WEGOVY (SEMAGLUTIDE 2.4 MG) IN SOUTH AFRICA
Further company coverage: [NOVOb.CO]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.